Ovarian Cancer is Not a Silent Killer – Recognizing Its Symptoms Could Help Reduce Misdiagnosis and Late Detection
Barbara Goff, MD discusses ovarian cancer and how recognizing symptoms can lead to early detection and reduce misdiagnosis.
Diagnosis & Disease Information
Surgery Plus Chemo Better for Treating Relapsed Ovarian Cancer
Overall survival longer with secondary cytoreductive surgery followed by platinum-based chemotherapy vs chemotherapy alone.
Oral Contraceptives Lower Ovarian Cancer Risk in BRCA Carriers
Findings seen in BRCA1 and BRCA2 mutation carriers; reduction greater with longer duration of use in BRCA1 carriers
Family History of Ovarian Cancer Linked to Breast Cancer Risk
A team of researchers sought to evaluate familial risks of developing breast cancer among women with a family history of cancers other than breast cancer.
Oral Contraceptives Protect Against Ovarian, Endometrial Cancer
Oral contraceptives have a lasting protective effect against ovarian and endometrial cancer, according to a new study.
Guidance for the Diagnosis and Management of Ovarian Cysts
The risk of developing benign ovarian cysts is up to 90% for premenopausal women and 75% for postmenopausal women.
CA125 Can Detect Ovarian Cancer in General Practice
And elevated CA125 indicates higher risk for other cancers, especially in women aged ≥50 years.
PTSD Symptoms Tied to Higher Risk for Ovarian Cancer
Correlation moderately attenuated after adjustment for health and ovarian cancer risk factors.
Intrauterine Device Use May Reduce Incidence of Ovarian Cancer
Novel noncontraceptive benefit seen for all intrauterine devices.
Zejula Gets Priority Review for Late Stage Ovarian Cancer Indication
The sNDA is supported by data from the multicenter phase 2 QUADRA trial that evaluated the safety and activity of Zejula in 463 patients.
- Loading...
Loading...
Next post in Oncology Information Center
Loading... 
Loading...